Stockholders' Deficiency - Summary of Warrants Outstanding (Detail) - Warrant [Member] |
3 Months Ended |
|---|---|
|
Sep. 30, 2022
$ / shares
shares
| |
| Class of Warrant or Right [Line Items] | |
| Beginning Balance, Shares | 0 |
| Granted | 400,000 |
| Exercised | (300,000) |
| Ending Balance, Shares | 100,000 |
| Weighted Average Exercise Price Granted | $ / shares | $ 4.25 |
| Weighted Average Exercise Price Exercised | $ / shares | 4 |
| Weighted Average Exercise Price | $ / shares | $ 5 |
| Weighted Average Remaining Contractual Term Granted | 5 years |
| Weighted Average Remaining Contractual Term | 4 years 10 months 24 days |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options exercises in period. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options granted weighted average remaining contractual terms. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award equity instruments other than options exercises in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award equity instruments other than options grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award equity instruments other than options outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|